BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27001960)

  • 1. Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus.
    Muthumani K; Block P; Flingai S; Muruganantham N; Chaaithanya IK; Tingey C; Wise M; Reuschel EL; Chung C; Muthumani A; Sarangan G; Srikanth P; Khan AS; Vijayachari P; Sardesai NY; Kim JJ; Ugen KE; Weiner DB
    J Infect Dis; 2016 Aug; 214(3):369-78. PubMed ID: 27001960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice.
    Tretyakova I; Hearn J; Wang E; Weaver S; Pushko P
    J Infect Dis; 2014 Jun; 209(12):1882-90. PubMed ID: 24585894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Immunization With CHIKV VLP and DNA Vaccines Induces a Promising Humoral Response in Mice.
    Zhao Z; Deng Y; Niu P; Song J; Wang W; Du Y; Huang B; Wang W; Zhang L; Zhao P; Tan W
    Front Immunol; 2021; 12():655743. PubMed ID: 33868299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus.
    Muthumani K; Lankaraman KM; Laddy DJ; Sundaram SG; Chung CW; Sako E; Wu L; Khan A; Sardesai N; Kim JJ; Vijayachari P; Weiner DB
    Vaccine; 2008 Sep; 26(40):5128-34. PubMed ID: 18471943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prime-boost immunization strategies against Chikungunya virus.
    Hallengärd D; Lum FM; Kümmerer BM; Lulla A; Lulla V; García-Arriaza J; Fazakerley JK; Roques P; Le Grand R; Merits A; Ng LF; Esteban M; Liljeström P
    J Virol; 2014 Nov; 88(22):13333-43. PubMed ID: 25210177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge.
    Choi H; Kudchodkar SB; Reuschel EL; Asija K; Borole P; Agarwal S; Van Gorder L; Reed CC; Gulendran G; Ramos S; Broderick KE; Kim JJ; Ugen KE; Kobinger G; Siegel DL; Weiner DB; Muthumani K
    Hum Vaccin Immunother; 2020 Apr; 16(4):907-918. PubMed ID: 31799896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system.
    Wu J; Zhao C; Liu Q; Huang W; Wang Y
    Vaccine; 2017 Nov; 35(47):6387-6394. PubMed ID: 29031692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates.
    Mallilankaraman K; Shedlock DJ; Bao H; Kawalekar OU; Fagone P; Ramanathan AA; Ferraro B; Stabenow J; Vijayachari P; Sundaram SG; Muruganandam N; Sarangan G; Srikanth P; Khan AS; Lewis MG; Kim JJ; Sardesai NY; Muthumani K; Weiner DB
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e928. PubMed ID: 21264351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves.
    R El-Attar LM; Thomas C; Luke J; A Williams J; Brownlie J
    Vaccine; 2015 Jul; 33(32):4004-12. PubMed ID: 26079613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chikungunya fever vaccine utilizing an insect-specific virus platform.
    Erasmus JH; Auguste AJ; Kaelber JT; Luo H; Rossi SL; Fenton K; Leal G; Kim DY; Chiu W; Wang T; Frolov I; Nasar F; Weaver SC
    Nat Med; 2017 Feb; 23(2):192-199. PubMed ID: 27991917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.
    Golden JW; Maes P; Kwilas SA; Ballantyne J; Hooper JW
    J Virol; 2016 Jan; 90(7):3515-29. PubMed ID: 26792737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus.
    Colombage G; Hall R; Pavy M; Lobigs M
    Virology; 1998 Oct; 250(1):151-63. PubMed ID: 9770429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.
    Roques P; Ljungberg K; Kümmerer BM; Gosse L; Dereuddre-Bosquet N; Tchitchek N; Hallengärd D; García-Arriaza J; Meinke A; Esteban M; Merits A; Le Grand R; Liljeström P
    JCI Insight; 2017 Mar; 2(6):e83527. PubMed ID: 28352649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
    Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
    MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2.
    Zhang HY; Sun SH; Guo YJ; Zhu WJ; Shi K; Xu GX; Wang JJ
    Vaccine; 2008 Feb; 26(6):769-77. PubMed ID: 18191307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutics and vaccines against chikungunya virus.
    Ahola T; Couderc T; Ng LF; Hallengärd D; Powers A; Lecuit M; Esteban M; Merits A; Roques P; Liljeström P
    Vector Borne Zoonotic Dis; 2015 Apr; 15(4):250-7. PubMed ID: 25897811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs.
    Sheng Z; Gao N; Cui X; Fan D; Chen H; Wu N; Wei J; An J
    Vaccine; 2016 Nov; 34(47):5751-5757. PubMed ID: 27743649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective Protection Induced by a Monovalent DNA Vaccine against Dengue Virus (DV) Serotype 1 and a Bivalent DNA Vaccine against DV1 and DV2 in Mice.
    Zheng X; Chen H; Wang R; Fan D; Feng K; Gao N; An J
    Front Cell Infect Microbiol; 2017; 7():175. PubMed ID: 28553618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective cutaneous vaccination using an inactivated chikungunya virus vaccine delivered by Foroderm.
    Rudd PA; Raphael AP; Yamada M; Nufer KL; Gardner J; Le TT; Prow NA; Dang N; Schroder WA; Prow TW; Suhrbier A
    Vaccine; 2015 Sep; 33(39):5172-80. PubMed ID: 26296498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious RNA vaccine protects mice against chikungunya virus infection.
    Szurgot I; Ljungberg K; Kümmerer BM; Liljeström P
    Sci Rep; 2020 Dec; 10(1):21076. PubMed ID: 33273501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.